These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35860003)

  • 1. Cantharidin Inhibits Proliferation of Liver Cancer by Inducing DNA Damage via KDM4A-Dependent Histone H3K36 Demethylation.
    Wei C; Deng X; Gao S; Wan X; Chen J
    Evid Based Complement Alternat Med; 2022; 2022():2197071. PubMed ID: 35860003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation.
    Ding G; Xu X; Li D; Chen Y; Wang W; Ping D; Jia S; Cao L
    Cell Death Dis; 2020 Oct; 11(10):893. PubMed ID: 33093461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Cantharidin Inhibits Proliferation of Liver Cancer by Inducing DNA Damage via KDM4A-Dependent Histone H3K36 Demethylation.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9785474. PubMed ID: 38125128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.
    Chen T; Liu R; Niu Y; Mo H; Wang H; Lu Y; Wang L; Sun L; Wang Y; Tu K; Liu Q
    Cell Death Dis; 2021 Dec; 12(12):1152. PubMed ID: 34903711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTCF-KDM4A complex correlates with histone modifications that negatively regulate
    Guerra-Calderas L; González-Barrios R; Patiño CC; Alcaraz N; Salgado-Albarrán M; de León DC; Hernández CC; Sánchez-Pérez Y; Maldonado-Martínez HA; De la Rosa-Velazquez IA; Vargas-Romero F; Herrera LA; García-Carrancá A; Soto-Reyes E
    Oncotarget; 2018 Mar; 9(24):17028-17042. PubMed ID: 29682202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
    Zhu M; Shi X; Gong Z; Su Q; Yu R; Wang B; Yang T; Dai B; Zhan Y; Zhang D; Zhang Y
    Pharmacol Res; 2020 Aug; 158():104868. PubMed ID: 32407961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response.
    Yan J; Deng XL; Ma SQ; Hui Li Y; Gao YM; Shi GT; Wang HS
    BMC Complement Med Ther; 2023 May; 23(1):160. PubMed ID: 37202806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.
    Shen HM; Zhang D; Xiao P; Qu B; Sun YF
    Cancer Gene Ther; 2023 Jul; 30(7):1007-1017. PubMed ID: 36973424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.
    Hong M; Li J; Li S; M Almutairi M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cantharidin inhibits cell proliferation and induces apoptosis through G2/M phase cell cycle arrest in hepatocellular carcinoma stem cells.
    Le AP; Zhang LL; Liu W; Shi YF
    Oncol Rep; 2016 May; 35(5):2970-6. PubMed ID: 26986084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
    Chen DB; Xie XW; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Fei R; Qin WY; Wang JH; Wu X; Shao QX; Wei L; Chen HS
    Sci Rep; 2020 Sep; 10(1):14538. PubMed ID: 32883983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
    Tian X; Zeng G; Li X; Wu Z; Wang L
    Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells.
    Kuo JH; Huang AC; Lin JJ; Lai KC; Wu RS; Yang JL; Ji BC; Yang MD; Chu YL; Chung JG
    Oncol Lett; 2017 Jul; 14(1):234-240. PubMed ID: 28693159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
    Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
    Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
    Xu MD; Liu SL; Zheng BB; Wu J; Wu MY; Zhang Y; Gong FR; Tao M; Zhang J; Li W
    Pancreatology; 2018 Oct; 18(7):822-832. PubMed ID: 30201439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and proliferation of human hepatocellular carcinoma.
    Hino N; Higashi T; Nouso K; Nakatsukasa H; Tsuji T
    Liver; 1996 Apr; 16(2):123-9. PubMed ID: 8740846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma.
    Chen M; Jiang Y; Sun Y
    Biochem Biophys Res Commun; 2021 Apr; 550():77-83. PubMed ID: 33689883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
    Li S; Hao L; Hu X; Li L
    Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_SPECC1 enhances the inhibition of miR-526b on downstream KDM4A/YAP1 pathway to regulate the growth and invasion of gastric cancer cells.
    Chen LH; Wang LP; Ma XQ
    Biochem Biophys Res Commun; 2019 Sep; 517(2):253-259. PubMed ID: 31349968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.